The Centers for Disease Control and Prevention (CDC) issued guidance on specific elements of consent as well as disclosures to support employee decision-making if/when employers incorporate workplace COVID-19 testing.
Differences in position and authority (such as workplace hierarchies), as well as employment status in nonstandard working arrangements (i.e., temporary help, contract help, or part-time employment), may affect an employee’s ability to make free decisions. This guidance suggests measures employers can take when developing a testing program.Â
highlights
- CDC guidance states that workplace testing should not be conducted without the employee’s informed consent.
- Informed consent requires disclosure, understanding and free choice.
- COVID-19 testing may be incorporated as part of a comprehensive approach to reducing transmission in non-health-care workplaces.
To fully support employee decision-making and consent, these measures should include:
- Safeguarding employees’ privacy and confidentiality;
- Providing information that is complete and understandable on how the employer’s testing program may impact employees’ lives;
- Explaining any parts of the testing program an employee would consider important when deciding to participate;
- Providing information about the testing program in the employee’s preferred language using nontechnical terms;
- Encouraging supervisors and co-workers to avoid pressuring employees to participate in the testing; and
- Encouraging and answering questions during the consent process.
ACTIONS TO TAKE
Employers should follow these measures to create a supportive environment when employees need to make decisions about workplace-based testing.Â
Additional employer resources
- CDC COVID-19 website
- Employer strategies for incorporating testing for COVID-19 in the workplace
- Nonstandard working arrangements information
DISCLOSURES FOR WORKPLACE TESTING
An employer’s testing program (including the implementation of a testing protocol to test employees) may be complex and technical. Certain aspects of the testing program may be more relevant than others to an employee’s decision whether to accept an offered test. The CDC’s SARS-CoV-2 Testing Strategy: Considerations for Non-Healthcare Workplaces identifies disclosures important for employees contemplating testing. Many of these disclosures are addressed in the U.S. Food and Drug Administration (FDA) emergency use authorization patient fact sheet for the test, which must be provided during the consent process. Those disclosures include:
- The manufacturer and name of the test;
- The test’s purpose;
- The type of the test;
- How the test will be performed;
- Known and potential risks of harm, discomforts and benefits of the test; and
- What it means to have a positive or negative test result including test reliability and limitations, public health guidance to isolate or quarantine at home, including:
- Test reliability and limitations; and
- Public health guidance to isolate or quarantine at home, if applicable.
Discussion Topics
Employers should be prepared to discuss the following topics:
Topic |
Questions to Address |
General Considerations |
|
Scheduling and Payment |
|
Testing Site |
|
Communication and Interpretation Results |
|
Privacy |
|
Seeking Additional Help or Reporting Injuries |
|
This Compliance Bulletin is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel for legal advice. ©2021 Zywave, Inc. All rights reserved.
Material posted on this website is for informational purposes only and does not constitute a legal opinion or medical advice. Contact your legal representative or medical professional for information specific to your legal or medical needs.